Results of the leeds assessment of neuropathic symptoms and signs pain scale in Turkey: A validation study

Yücel, Ayşen; Şenocak, Mustafa; Orhan, Elif Kocasoy; Çimen, Ali; Ertaş, Mustafa

doi:10.1016/j.jpain.2004.07.001

Cited by 137 publications

(106 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Turkish LANSS has a sensitivity of 89.9% and a specificity 94.2%, and a positive predictive value of 93.6% and a negative predictive value of 90.7% [10]. The Spanish LANSS has good reliability with Cronbach and Guttman split-half coefficients between 0.68 and 0.71 and a kappa coefficient for inter-rater agreement of 0.70 and intra-class correlation coefficients between 0.77 and 0.92.…”

Section: Discussionmentioning

confidence: 99%

“…74% and 76%, respectively) with an ability to identify neuropathic pain in 75% of patients with clinically confirmed diagnosis of neuropathic pain [3]. Specificity and sensitivity remain stable when translated versions of the LANSS and S-LANSS are used in non-English speaking populations including Turkish [10,11], Spanish [12] and Chinese [13]. The LANSS pain scale has been translated, linguistically validated and culturally adapted for use in Turkish, Dutch, Spanish, French and Chinese populations [10,13,14].…”

Section: Introductionmentioning

confidence: 99%

“…Specificity and sensitivity remain stable when translated versions of the LANSS and S-LANSS are used in non-English speaking populations including Turkish [10,11], Spanish [12] and Chinese [13]. The LANSS pain scale has been translated, linguistically validated and culturally adapted for use in Turkish, Dutch, Spanish, French and Chinese populations [10,13,14]. The S-LANSS has been translated, linguistically validated and culturally adapted for use in Arabic populations [9], but there is no equivalent LANSS pain scale for use in Arabic populations.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Garoushi

Johnson

Tashani

2017

Libyan Journal of Medicine

View full text Add to dashboard Cite

In Libya neuropathic pain is rarely assessed in patients with diabetes. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale is used worldwide to screen for neuropathic pain. There is no Arabic version of LANSS for use in Libya. The aim of this study was to develop an Arabic version of LANSS and to assess its validity and reliability in diabetic patients in Benghazi, Libya. LANSS was translated into Arabic by four bilingual translators and back translated to English by a university academic. Validity and reliability of the Arabic LANSS was assessed on 110 patients attending a Diabetes Centre in Benghazi. Concurrent validity was tested and compared with the Self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS). Test-retest reliability was conducted 1–2 weeks later. Internal consistency and inter-class correlation (ICC) between LANSS and S-LANSS was also tested. Internal consistency within first completion of the Arabic LANSS was acceptable (Cronbach’s alpha = 0.793) and similar to the Arabic S-LANSS (0.796) and the second completion of the Arabic LANSS (0.795). ICC between the Arabic LANSS and the Arabic S-LANSS was 0.999 (p < 0.001). Test-retest reliability (ICC) between first and second completions of the Arabic LANSS was 0.999 (p < 0.001). Kappa measurement of agreement between the two Arabic LANSS completions and S-LANSS was high on all seven items (Kappa >0.95, p < 0.0001). We concluded that the Arabic version of LANSS pain scale was valid and reliable for use on Libyan diabetic patients. This study provided results suggesting that the S-LANSS could also be used on diabetic patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Garoushi

Johnson

Tashani

2017

Libyan Journal of Medicine

View full text Add to dashboard Cite

show abstract

“…15 The Turkish version of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale was used to discriminate between neuropathic and non-neuropathic pain. 16 It evaluates five types of pain: (a) thermal, (b) dysesthesia, (c) paroxysmal, (d) evoked and (e) autonomic dysfunction. Scores of 12 or higher (out of a total of 24) were considered neuropathic pain.…”

Section: Methodsmentioning

confidence: 99%

Effects of chronic pain on quality of life and depression in patients with spinal cord injury

Ataoglu¹,

Tiftik²,

Kara³

et al. 2012

Spinal Cord

124

View full text Add to dashboard Cite

esign: A cross-sectional study. Objective: To assess the effects of pain on quality of life (QoL), functional independence and depression in patients with spinal cord injury (SCI). Setting: An inpatient rehabilitation center. Methods:A total of 140 patients (104 M, 36 F) with SCI who underwent inpatient rehabilitation treatment were examined. A questionnaire including clinical variables was applied. Motor score of Functional Independence Measure was used to assess dailylife activities, the 36-Item Medical Outcomes Short-Form Health (SF-36) for QoL and Beck Depression Inventory (BDI) for depression. Patients were then divided into those having chronic pain (Group I) and those without any pain (Group II), and groups were compared according to demographic and clinical variables. Results: The most common causes of SCI were falls (35.0%) and motor vehicle accidents (34.2%). Chronic pain was present in 78% of patients. Patients employed before injury and patients who had complete injury had lower Numerical Rating Scale scores (Po0.05). SCI patients with chronic pain had higher depression ratings and their BDI scores were correlated with some of the SF-36 domains (general health, vitality, social functioning and mental health). Only bodily pain and social functioning (Po0.05) scores were found to be lower in Group I (Po0.05) when compared with Group II. Conclusion: As mood and QoL are negatively affected with pain in SCI patients, we suggest that chronic pain should always be treated in a multidisciplinary setting where pharmacological, physical and psychological therapies are combined.

show abstract

“…10,29 The LANSS scale has been tested and validated in several clinical settings with around 80-85% accuracy when compared with expert clinical evaluation. 2,9,38,39 Other scales that have since been developed and validated include the Neuropathic Pain Questionnaire (NPQ) and the Douleur Neuropathique (DN4) (see Table II). These questionnaires enable the clinician to decide if NP is the "dominant pain mechanism" in a patient with chronic pain.…”

Section: Screening Toolsmentioning

confidence: 99%

Neuropathic pain—Current concepts

Meyer

2008

South African Family Practice

View full text Add to dashboard Cite

Neuropathic pain (NP) represents a common and diverse group of disorders with peripheral and/or central nervous system damage or dysfunction. Many patients report intractable and severe pain that is resistant to simple analgesics. The diagnosis of NP is primarily based on clinical evaluation rather than diagnostic tests. Distinct pain qualities in the patient's history and findings on clinical examination, such as hyperalgesia and other sensory findings in an area correlating with the patient's pain pattern are important in diagnosis. Various screening tools may assist in the diagnosis of NP.A number of pathophysiological mechanisms have been identified in NP, including sodium-and calcium-channel upregulation and spinal cord hyperexcitability (central sensitisation).Appropriate management includes evaluation of the functional impact of NP, patient education and reassurance. A multi-model biopsychosocial approach that includes various nonpharmacological modalities is recommended. Appropriate pharmacological management is based on evidence-based recommendations that provide guidance for selecting first-, second-and third-line medications, alone or in combination. It is hoped that future treatment advances will improve the care of patients who live with NP.

show abstract

Results of the leeds assessment of neuropathic symptoms and signs pain scale in Turkey: A validation study

Cited by 137 publications

References 11 publications

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Effects of chronic pain on quality of life and depression in patients with spinal cord injury

Neuropathic pain—Current concepts

Contact Info

Product

Resources

About